Six-day allosensitized human peripheral blood lymphocytes treated for 12-18 hr with phorbol 12-myristate 13-acetate (PMA) were found to lose the capacity to kill the specific target in a standard cell-mediated lympholysis (CML) assay, but they were still effective in their ability to kill the tumor cell line K562. We investigated which antigens on the cell membrane involved in alloimmune recognition might be modified by PMA, since it was found that in a lectin-dependent CML assay, the lytic mechanism was not impaired. For this purpose, T3V, T4' allospecific cytotoxic T lymphocyte (CTL) clones and either T3+ or T3-natural killer (NK) clones were generated from 6-day allostimulated lymphocytes. The results indicated that PMA inhibited the cytolytic function of both alloimmune CTL and NK T3+ clones. In contrast, PMA did not modify the effector cell function of T3-NK clones. Phenotypic analysis of T-cell surface antigens from T3+ clones showed that T3 molecule expression on the cell membrane was reduced by 80-90% after PMA treatment, whereas expression of both accessory T4 molecules, involved in antigen recognition, and receptor for interleukin 2 was increased. Moreover, the loss of function was transitory and could be restored 4 days after PMA treatment when the T3 molecules were fully reexpressed at the cell surface. Taken together, these data strongly suggest that (i) PMA prevents cell-mediated cytotoxicity by modulating the disulfide-linked heterodimer associated to T3 and described as the receptor for antigen on the cell surface of major histocompatibility complex (MHC) and non-MHC specific CTL clones, without affecting the lytic mechanism per se, and (ii) the expression of the receptor for the antigen present on the tumor cell line K562 is not decreased on T3-NK clones after PMA treatment and must be different from that on T3+ T-cell clones.
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Tumor-promoting phorbol esters are chemical agents known to induce tumors in vivo when applied to animals that have received low doses of a carcinogen (1) . When used in vitro on malignant cells or normal cell lines, they were found to act on cell differentiation (2, 3) and or activation (4) . Recently, it has been shown that phorbol esters in the presence of anti-T3 antibodies were able to induce interleukin 2 (IL-2) and interferon y (IFN-y) production in some human T-cell lines (5) and also peripheral blood T-cell proliferation in the absence of monocytes (6) . Specific proliferation of normal human T lymphocytes is regulated via the cell-surface receptor expression for the antigen. The basic antigen/major histocompatibility complex (MHC) recognition unit of the T cell has been defined as a clonotypic, disulfide-linked heterodimer (Ti) associated with T3 molecules. T3-Ti receptor triggering by the specific antigen leads to IL-2 receptor (IL-2R) expression on the cell membrane and IL-2 production by some T-cell subsets (7) . Following IL-2 molecule-IL-2R interaction, DNA synthesis and cell division occur (8) . During the process of lymphocyte activation by specific antigen but also by PMA, IL-2R expression was found to be increased, whereas T3-Ti antigen receptor expression was decreased. Moreover, these phenotypic changes on the cell membrane were accompanied by enhanced IL-2 sensitivity and temporary lack of responsiveness to the antigen (9, 10). The PMA capacity for inducing modifications of T-cell surface antigens was used to correlate them with specific and nonspecific MHC cytotoxic T lymphocyte (CTL) function.
We describe here that after appropriate PMA treatment or addition of anti-T3 antibodies into cultures of 6-day allosensitized human lymphocytes, cytotoxicity mediated by alloimmune CTL was inhibited, whereas natural killer (NK) cell activity remained unchanged. However, in a lectin-dependent cell-mediated lympholysis (CML) assay, both activities were maintained. To further investigate these data, CTL clones and either T3+ or T3 NK clones were developed and treated with phorbol 12-myristate 13- Production of IL-2. IL-2-containing supernates were produced by stimulating peripheral blood mononuclear cells (PBMC) with phytohemagglutinin (PHA) (Wellcome) and PMA in the presence of irradiated EBV-transformed B-cell lines as described (12) .
Generation and Growth of Human T-Cell Clones. All of the T-cell clones used in the present study were generated from a single individual's mononuclear cells stimulated in MLC. The donors of the responder and stimulator cells were two brothers from the family Pers. Their class II MHC products differed. Cloning and recloning were performed as described (12) . Briefly, PBMC from VER (HLA-A11; C-; B38.4; DQ1; MT2; DR14/A2; C-; B51.4; DQ2; MT3; DR7) were stimulated with an equal concentration of irradiated PBMC from CHR (HLA-A11; C-; B38.4; DQ1; MT2; DR14/A2; C-; B51.4; DQ2; MT2; DR3) for 6 days in RPMI 1640 medium supplemented with 10% human AB serum. Activated cells were cloned in a two-layer soft agar system. After 6-9 days agar colonies were individually transferred into round-bottomed microtiter plates (Costar, Cambridge, MA) containing 0.75 x 105 irradiated PBMC from CHR in 0.1 ml. At that time the culture medium was supplemented with 10% IL-2. Subsequently, the cultures were expanded by feeding them every 2 or 3 days with IL-2-conditioned medium and restimulation on a weekly basis with irradiated feeder cells. The cells were recloned by limiting dilution in Terasaki plates at 0.3 cell per well in the presence of 5% IL-2 and irradiated feeder cells. The human T-cell clones were grown in continuous cultures for 3 months. To maintain JAF9 and JAF21 in culture after the cloning procedure, feeder cell suspensions of irradiated autologous PBMC and irradiated specific EBV-transformed CP cell lines derived from CHR PBMC were used in IL-2-conditioned medium. For the propagation of the T3 (LC3) and T3+ (LC5) NK cell clones, a pool of irradiated PBMC with IL-2-conditioned medium containing 1 ug of PHA (Wellcome) per ml was used as feeder cells.
Phenotypic Analysis of T-Cell Surface Antigens. Phenotypic analysis of T lymphocytes was performed by means of indirect immunofluorescence with a panel of monoclonal antibodies (kindly provided by E. L. Reinherz and S. F. Schlossman, Dana-Farber Cancer Institute, Boston, MA) and goat anti-mouse F(ab')2 fluorescein isothiocyanate (Tago, Burlingame, CA) by using a cytofluorograph (Ortho Diagnostics). The T-cell clones JAF9 and JAF21 were found to be T3+, T4+, T8-, IL-2R+, T11+, and Ia+. LC3 was T3, T4-, T8-, IL-2R+, T11+, Ia+. The anti-Ia framework (monomorphic 9-49) was kindly provided by R. Tood (University of Michigan Medical Center, Ann Arbor, MI).
Proliferative Studies. To investigate the effect of PMA (Sigma) treatment on proliferation, the T-cell clones JAF9, JAF21, and LC3 were incubated overnight (12 hr) with 1 CML. To analyze the functional effect of PMA on the cytotoxic effector function of either 6-day allosensitized lymphocytes or T-cell clones from JAF9, JAF21, or LC3, the cells were incubated for 12 hr with PMA or medium and subsequently were washed prior to the addition of 51Cr-labeled target cells. In the lectin-dependent assays 20 ug of Con A per ml was added to the cultures. These experiments were performed at effector/target cell ratios (E/T) of 20:1 and 10:1 in V-bottomed microtiter plates (Falcon Labware) according to a standard method (13) . Each value represents the mean of triplicate cultures; the standard deviation never exceeded 10%.
RESULTS
Allosensitized human lymphocytes, generated in a 6-day MLC, were pretreated with 1 nM PMA; they were then washed three times prior to the CML assay, using as targets, the specific and allogeneic PHA lymphoblasts and also the K562 tumor cell line. CML assays were also performed in the presence of anti-T3 or anti-T4 and anti-T8 antibodies at a final dilution of 1:300. Moreover, the CML assays were carried out in the presence or absence of Con A at a final concentration-of 20 /ig/ml. As shown in Table 1 , with one representative experiment among four performed with reproducible results, cytotoxicity mediated by alloimmune CTL was significantly reduced after PMA treatment and in the presence of anti-T3 or anti-T4 and anti-T8 antibodies. In contrast, the NK activity of allosensitized cells was maintained. In addition, the ability of alloimmune specific CTL and NK cells to kill, in a lectin-dependent cytotoxic assay, was neither modified by PMA treatment nor by the addition of anti-T3 or anti-T4 and anti-T8 antibodies to cultures.
To analyze these results more precisely, MHC specific and nonspecific CTL clones were developed from 6-day allostimulated lymphocytes. Six alloimmune T3+, T4+ CTL clones were studied; they were found to be specific for MHC class II antigens, since they had been generated in a family with a maternal crossover between class I and class II MHC Effector T cells from 6-day MLC of CAS anti-BLA* were incubated with PMA or medium for 12 hr and were washed three times. Then only those in medium were incubated with various monoclonal antibodies or medium before testing the cytolytic activity directed against 51Cr-labeled specific PHA lymphoblasts or K562 tumor cells. Con A was added to the CML assays at a final concentration of20 ,ug/ml. The different monoclonal antibodies (anti-T3, anti-T4, and anti-T8) were used at a final dilution of 1:300. The numbers correspond to the mean of triplicate cultures (SD < 10%1 of maximal lysis). antigens. In the sensitizing mixture, a HLA-DR3 incompatibility existed between responder and stimulator cells.
Among the NK clones produced, four were T11', T3-and one was T4', T3'. All clones were pretreated overnight with 1 nM PMA prior to proliferative and cytotoxic assays.
The results obtained with two representative T3', T4' alloimmune CTL clones, named JAFi and JAF21, and one T3 clone with NK cell activity, named LC3, are given in Table 2 . The two alloimmune CTL clones were found to respond to the specific stimulator and IL-2. After PMA treatment, specific antigen recognition and IL-2-induced proliferation were reduced. The T3-NK clone LC3 did not respond to the original stimulator used to generate these clones but was able to proliferate in response to IL-2. However, after PMA treatment, IL-2 responsiveness was reduced.
To further investigate the effect of PMA on cell-mediated cytotoxicity performed with the same T-cell clones, CML assays, using as targets the specific and allogeneic EBVtransformed cell lines and also the tumor cell line K562, were performed with and without lectins. As shown in Table 3 (15, 16) . With regard to lymphoid T cells, phenotypic modifications following PMA treatment concerned mainly T-cell surface markers such as the T3-Ti complex, which is known to be involved in specific antigen recognition, and the IL-2R, which is mainly associated with DNA synthesis and cell division.
In the present study, PMA was used to correlate phenotypic modifications with cell proliferation and cytotoxicity mediated either by alloimmune specific CTL or NK cells. Allogeneic target JFP 20:1  2  1  3  2  3  3  10:1  3  0  4  2  1  5  20:1  40  38  39  43  21  23  10:1  25  23  27  24  19  17   Tumor cell line K652  20:1  2  0  3  6  51  49  10:1  1  0  0  4  37  40  20:1  29  36  33  34  49  48  10:1  17  12  31  29  35  33 The T-cell clones JAF9, JAF21, and LC3 were individually incubated for 12 hr with PMA or medium and were washed three times. CML assays were then performed in the presence or absence of Con A at a final concentration of 20 ,ug/ml. The numbers correspond to the mean of triplicate cultures (SD < 10%o of maximal lysis). Cell-mediated cytotoxicity is well defined in terms of structures involved in antigen recognition and lysis: at the effector cell level, in addition to the T3-Ti complex, accessory molecules such as T4, T8, and LAFi are involved in T-cell recognition and function. The respective targets for alloimmune specific CTL clones, either T8+ or T4+, are the MHC class I and class II antigens (17, 18) . Non-MHC determinants have been described as targets for NK clones (19) .
According to our results with bulk (nonclonal) cultures, PMA treatment or the addition of anti-T3 or anti-T4 and anti-T8 antibodies was able to inhibit specific alloimmune cytotoxicity without affecting NK activity. The results obtained with anti-T4 and anti-T8 antibodies are not surprising since most of the specific alloimmune CTL are either T4+ or T8+ cells. In addition, anti-T3 antibodies have been shown to inhibit specific antigen recognition by modulating the T3-Ti complex (20) . The interesting finding concerns the PMA-induced effect. Since the lytic mechanism of both alloimmune and NK cells was not affected in a lectin-dependent cytotoxic assay, it was necessary to determine whether PMA-induced modifications of cell membrane recognition structures might be responsible for the loss of CTL effector function. Moreover, the loss of alloimmune cytoxicity could not be attributed to a toxic effect of PMA; MLC proliferation was, in fact, not decreased and was even enhanced (data not shown). The fact that PMA's effect was added 1 day before the CML assay also excluded the possibility that PMA might alter the frequency of allospecific CTL precursors.
To further investigate the effect of PMA on cell-mediated cytotoxicity, T3+ alloimmune specific CTL clones and T3+ and T3-NK clones were developed. After PMA treatment, specific antigen recognition and IL-2-induced proliferation of T3+ clones were found to be reduced. As we had found previously that cell surface IL-2R expression was not diminished after PMA treatment, it could be postulated that a decrease in IL-2 responsiveness might result from the appearance of low-affinity IL-2R on the cell membrane. Nevertheless, IL-2 responsiveness was recovered and enhanced 4 days after PMA treatment (data not shown), which correlates with the usual increase in IL-2R expression observed after PMA treatment (9, 10) .
The results obtained with the alloimmune specific CTL clones JAF9 and JAF21 and the NK clone LC3 were similar to those obtained with lymphocyte bulk cultures: the cytotoxicity mediated by specific alloimmune CTL expressing T3-Ti was reduced after PMA treatment or after the addition ofeither total anti-T3 antibodies or F(ab')2 fragments of those antibodies purified on protein A. This was also the case for the T3' NK clones (data not shown). Phenotypic analysis of T-cell markers performed for alloimmune specific CTL clones gave the following results after PMA treatment: T3 expression on cell membrane was decreased; in contrast, T4 expression was unmodified or was even slightly enhanced. Therefore, the loss of specific killing and specific proliferation seemed to be associated with the decrease in T3 molecule expression on the cell membrane. However, this effect was transient since specific cytotoxicity as well as specific proliferation (data not shown) could be restored 5 days after PMA treatment. The loss of function could not be attributed to a failure in the lytic mechanism; the inhibitory effect was, indeed, reversed in the presence of lectins. On the other hand, the killing ability of the T3-NK clones analyzed in this study was not affected after PMA treatment. These data strongly suggest that PMA was able to inhibit the allospecific cytotoxicity and the T3+ NK-mediated cytotoxicity (data not shown), by modulating the T3-Ti complex expression at the cell membrane. Furthermore, the results indicate that most of the NK-activated cells in the bulk cultures were T3-and therefore were neither blocked by PMA or anti-T3 antibodies, suggesting that (i) the NK T-cell clones using the T3-Ti structures, as reported by Hercend et al. (21) , might represent a minority of NK-activated cells selected by the in vitro procedure used to expand them and (it) the cell surface Taken together, these data favor PMA's interference in cell-mediated cytotoxicity via the structures involved in specific antigen recognition-mainly, the T3-Ti complexwithout affecting the lytic mechanism per se. It should be pointed out that the loss of function induced by PMA was transitory and could be restored 5 days after PMA treatment.
